AstraZeneca Pharma India Ltd Releases Business Responsibility and Sustainability Report for FY 2025-26
AstraZeneca Pharma India Limited has released its Business Responsibility and Sustainability Report (BRSR) for the financial year ended March 31, 2026. The report provides detailed insights into the company's operations, sustainability commitments, and adherence to ethical standards across various principles.The document outlines AstraZeneca's commitment to improving the health of people, society, and the planet through science-led and patient-focused activities, emphasizing the interconnectedness of planetary and population health.
Operational Overview and Business Profile
AstraZeneca Pharma India Limited is a global, science-led pharmaceutical business committed to excellence in the research, development, and commercialization of prescription medicines.The company's key operational details for the reporting year are summarized below:
| Metric | Detail |
|---|---|
| Financial Year | 2025-26 |
| Total Paid-up Capital | INR 50,000,000 |
| Primary Activity (90% of turnover) | Marketing and trading of pharmaceutical products |
| Products Sold (100% of consolidated turnover) | Drugs and Pharmaceutical products |
| Registered Office Address | Block N1, 12th Floor, Manyata Embassy Business Park, Bangalore-560045, India |
| Total Employees | 760 |
The company operates across both national and international markets. Of the total turnover of
22,755.8 million, export sales contributed 1,175.6 million, accounting for 5.2%. The customer base includes distributors, hospitals, and Government institutions.Sustainability Performance Metrics
The report provides extensive metrics across climate action, resource management, waste, and human capital development.Climate Action and Energy Footprint
A key focus of the company's sustainability strategy is decarbonizing operations while advancing sustainable patient care. AstraZeneca reported significant progress in environmental footprint reduction:| Parameter | FY 2025-26 | FY 2024-25 | Metric Unit |
|---|---|---|---|
| Total Scope 1 Emissions | 88.31 | 312.04 | Metric tonnes of CO2 equivalent |
| Total Scope 2 Emissions | 452.70 | 1,233.65 | Metric tonnes of CO2 equivalent |
| Energy Intensity (per rupee of turnover) | 0.46 | 1.33 | GJ/ ` million |
The company noted an 88% reduction in Scope 1 and 2 emissions from its sites and fleet since 2015, which coincided with more than doubling its revenue.
Resource Management and Waste
In terms of environmental protection, the report details resource consumption and waste management practices:| Parameter | FY 2025-26 | FY 2024-25 | Metric Unit |
|---|---|---|---|
| Total Water Consumption | 7,691.06 | 22,150.22 | kiloliters (KL) |
| Water Intensity (per rupee of turnover) | 0.34 | 1.29 | KL / ` million |
| Total Waste Generated | 10.89 | 26.26 | metric tonnes |
The company confirmed that all generated effluent is 100% treated in-house at the Combined Effluent Treatment Plant and used for landscaping purposes within the manufacturing plant. All waste, including hazardous materials, is disposed to KSPCB authorised recyclers or BBMP authorised vendors.
Governance and Human Capital
The report emphasizes a strong commitment to corporate values, ethical conduct, and employee wellbeing. The company employs 760 permanent employees, with gender distribution showing 558 male and 202 female employees (100% of permanent staff).| Employment Metric | FY 2025-26 |
|---|---|
| Total Permanent Employees | 760 |
| Female Employees as % of total | 27% |
| Gross Wage paid to Females as % of total wages | 25.54% |
In terms of human rights and ethical standards, the company ensures that Abiding by Human Rights is a part of all contractor agreements, backed by a formal 'Bullying and Harassment Policy.' Training programs have been conducted for various staff categories:
| Category | Training Coverage FY 2025-26 |
|---|---|
| Board/KMP | 14 programmes (100% coverage) |
| Employees (Other than BoD and KMP) | 14 programmes (100% coverage) |
| Personnel (KMPs) | 140 programmes (100% coverage) |
Stakeholder Engagement and Risk Mitigation
The company identifies the importance of managing interconnected challenges, including climate change and health equity. A materiality assessment guided by the AstraZeneca Group identified Climate Action as an Opportunity, with the company leveraging its $1bn Ambition Zero Carbon programme globally to reduce GHG emissions across operations.Regarding consumer protection, the company operates a dedicated email ID and online tool for registering product quality complaints. There were 4 such complaints received during FY 2025-26, none of which were pending resolution at the end of the year.
The management team is responsible for designing and maintaining internal controls related to the preparation of this Identified Sustainability Information (ISI), while those charged with governance are tasked with overseeing the entire reporting process.
ASTRAZEN Stock Price Movement
Shares of AstraZeneca Pharma India Limited slipped by 0.81% on Friday, closing at ₹8023.5 after shedding ₹65.50 from the previous close. The equity traded within a range of ₹7933 and ₹8170 during the session, with total volume registering at 8914 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.